CN212502582U

CN212502582U - Drug delivery structure and device thereof

Info

Publication number: CN212502582U
Application number: CN201922349067.7U
Authority: CN
Inventors: 周星汉; 黎超强; 方德忠; 植赐波; 张晓�
Original assignee: Shenzhen Nubomed Technology Co Ltd
Current assignee: Shenzhen Nubomed Technology Co Ltd
Priority date: 2019-12-24
Filing date: 2019-12-24
Publication date: 2021-02-09
Anticipated expiration: 2029-12-24

Abstract

The utility model provides a medicine conveying structure, through the two liang of locks of first connecting piece and second connecting piece after, fixed by the fixed column again, consequently, the back is connected with its two long bottom surfaces formation accommodating space to the two short bottom surfaces of first connecting piece and second connecting piece for accept the medicine. In the process of rotating the medicine conveying structure, the medicine in the accommodating space can be driven to move, and then the medicine conveying is realized. Furthermore, a drug delivery device is provided.

Description

Drug delivery structure and device thereof

Technical Field

The utility model relates to a medicine conveying, in particular to medicine conveying structure and device that simple structure, can singly manage.

Background

Along with the development of modernization, medical electronic equipment is more and more popularized, and the degree of becoming more and more high to medicine management and control is wisdom hospital. In traditional medicine management, a medicine administrator or medical staff manually registers to ensure that the medicines are managed and stored according to regulations as much as possible, but the manual registration inevitably causes situations of missed note, wrong note or medicine loss and the like, so that the safety of the medicines is difficult to ensure, and the medicine management efficiency is low.

SUMMERY OF THE UTILITY MODEL

In view of the above, there is a need for a drug delivery structure that is simple in construction and capable of single-limb administration.

A drug delivery structure comprises a fixed column, a plurality of first connecting pieces and a plurality of second connecting pieces;

the first connecting piece is generally L-shaped, and two long side edges of the short bottom surface of the first connecting piece are respectively provided with a first connecting column;

the second connecting piece is generally L-shaped, and two long side edges of the short bottom surface of the second connecting piece are respectively provided with a second connecting column 203 corresponding to the first connecting column;

after the first connecting columns and the second connecting columns 203 are buckled pairwise, the medicine conveying structure is formed by fixedly connecting the fixing columns.

In one embodiment, the connector further comprises a third connector, the first connecting column and the second connecting column 203 are respectively arranged on two long side edges of the third connector, the first connecting column of the third connector is buckled with the second connecting column 203 of the second connector and then fixedly connected through the fixing column, and the second connecting column 203 of the third connector is buckled with the first connecting column of the first connector and then fixedly connected through the fixing column.

In one embodiment, the first connecting columns comprise discontinuously arranged first round connecting columns and first semicircular connecting columns, and the first round connecting columns and the first semicircular connecting columns are arranged on one axis; the second connecting column 203 comprises a second circular connecting column and a second semicircular connecting column which are discontinuously arranged, and the second circular connecting column and the second semicircular connecting column are arranged on the same axis.

In one embodiment, the light blocking sheet is vertically arranged on the short bottom surface of the first connecting piece or the short bottom surface of the second connecting piece.

Furthermore, there is a need to provide a drug delivery device that is simple in construction and capable of single administration.

A drug delivery device comprises the drug delivery structure, a source drive module for providing a driving force, a main drive module and a housing;

the driving force of the source driving module is transmitted to the main driving module; the main driving module is used for driving the medicine conveying structure to rotate around the main driving module; when the medicine conveying structure rotates, the medicine arranged in the medicine conveying structure is driven to move; the housing is configured to receive the source drive module, the primary drive module, and the drug delivery structure; the shell is also provided with a medicine outlet.

In one embodiment, the source driving module includes a motor and a first rotating wheel, the motor is fixedly connected to the first rotating wheel, and the motor drives the first rotating wheel to rotate when rotating.

In one embodiment, the system further comprises a transmission module respectively connecting the source driving module and the active driving module;

the transmission module is used for transmitting the driving force of the source driving module to the main driving module.

In one embodiment, the transmission module includes a second wheel, the second wheel is connected to the source driving module, and the source driving module drives the second wheel to rotate when rotating.

In one embodiment, the main driving module comprises a third rotating wheel, a first rotating shaft and a first chain wheel;

the first rotating shaft penetrates through the first chain wheel, one free end of the first rotating shaft is fixedly connected with the axis of the third rotating wheel, and the other free end of the first rotating shaft is accommodated in the shell; when the third rotating wheel rotates, the first rotating shaft is driven to rotate, and then the first chain wheel is driven to rotate.

In one embodiment, the device further comprises a slave driving module, wherein the slave driving module is arranged opposite to the master driving module, so that the transmission module rotates around the master driving module and the slave driving module simultaneously.

In one embodiment, the slave driving module comprises a second rotating shaft and a second chain wheel;

the second rotating shaft penetrates through the second chain wheel, one free end of the second rotating shaft is movably connected with the axis of the fourth rotating wheel, and the other free end of the second rotating shaft is accommodated in the shell; when the fourth rotating wheel rotates, the first chain wheel is driven to rotate, and the first rotating shaft is further driven to rotate.

In one embodiment, the housing comprises a receiving groove and a top cover; the accommodating groove is used for accommodating the source driving module, the main driving module and the medicine conveying structure, and is also provided with the medicine outlet; one side of the opening of the containing groove is movably connected with the top cover.

In one embodiment, the medicine delivery device further comprises a first bottom cover and a second bottom cover, and the first bottom cover and the second bottom cover respectively cover two side surfaces formed when the medicine delivery structure rotates around the main drive module.

The medicine conveying structure is buckled pairwise through the first connecting piece and the second connecting piece and then fixed by the fixing column, so that the two short bottom surfaces of the first connecting piece and the second connecting piece are connected and then form an accommodating space with the two long bottom surfaces of the first connecting piece and the second connecting piece for accommodating medicines. In the process of rotating the medicine conveying structure, the medicine in the accommodating space can be driven to move, and then the medicine conveying is realized.

Above-mentioned medicine transmission device provides drive power through source drive module, makes main drive module rotate, and then main drive module drives the motion of medicine conveying structure, and the medicine of arranging in the medicine conveying structure then can follow the motion of medicine conveying structure, uses the shell to accept source drive module, main drive module and medicine conveying structure, can avoid the medicine to scatter in data send process, and then realizes the medicine conveying. Compared with the traditional medicine conveying device, the medicine conveying device has the advantages that components are reduced, and further the product cost is reduced.

Drawings

FIG. 1 is a schematic view of a drug delivery configuration;

FIG. 2 is a schematic structural view of a first connecting member;

FIG. 3 is a schematic structural view of a second connector;

FIG. 4 is a schematic structural view of a third connecting member;

FIG. 5 is a block diagram of a drug delivery device;

FIG. 6 is a schematic structural diagram of a main driving module, a transmission module, and a source driving module;

FIG. 7 is a schematic structural diagram of a slave drive module;

FIG. 8 is one of the schematic structural views of a drug delivery device;

fig. 9 is a second schematic structural view of the drug delivery device.

Detailed Description

In order to make the above objects, features and advantages of the present invention more comprehensible, embodiments of the present invention are described in detail below with reference to the accompanying drawings. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. The present invention can be embodied in many different forms other than those specifically described herein, and it will be apparent to those skilled in the art that similar modifications can be made without departing from the spirit and scope of the invention, and it is therefore not to be limited to the specific embodiments disclosed below.

It will be understood that when an element is referred to as being "secured to" another element, it can be directly on the other element or intervening elements may also be present. When an element is referred to as being "connected" to another element, it can be directly connected to the other element or intervening elements may also be present. The terms "vertical," "horizontal," "left," "right," and the like as used herein are for illustrative purposes only and do not represent the only embodiments.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.

As shown in fig. 1, the drug delivery structure is schematically illustrated.

A drug delivery structure 200 comprises a fixing column (not marked), a plurality of first connecting pieces 10 and a plurality of second connecting pieces 20;

the first connecting piece 10 is generally L-shaped, and two long sides of the short bottom surface of the first connecting piece 10 are respectively provided with a first connecting column 103;

the second connecting piece 20 is generally L-shaped, and two long sides of the short bottom surface of the second connecting piece 20 are respectively provided with a second connecting column corresponding to the first connecting column 103;

the plurality of first connecting columns 103 and the plurality of second connecting columns are fastened in pairs and then fixedly connected through the fixing columns (not labeled) to form the drug delivery structure 200.

Please refer to fig. 2. The first connecting member 10 includes a first long bottom surface 101, a first short bottom surface 102, and a first connecting pillar 103. The first long bottom surface 101 and the first short bottom surface 102 are substantially perpendicular to each other, the first connecting column 103 is disposed on the edge formed by the intersection of the first long bottom surface 101 and the first short bottom surface 102, and the first connecting column 103 is disposed in parallel on the other edge of the first short bottom surface 102. Namely, two parallel first connecting posts 103 are disposed on two opposite long sides of the first short bottom surface 102.

Please refer to fig. 3. The second connecting member 20 includes a second long bottom surface 201, a second short bottom surface 202 and a second connecting column. The second long bottom surface 201 and the second short bottom surface 202 are substantially perpendicular to each other, a second connecting column is arranged on the edge formed by the intersection of the second long bottom surface 201 and the second short bottom surface 202, and a second connecting column is arranged in parallel on the other edge of the second short bottom surface 202. I.e. two parallel second connecting columns are arranged on two opposite long sides of the second short bottom surface 202.

The first long bottom surface 101 of the first connector 10 is attached to the second long bottom surface 201 of the second connector 20, and the first short bottom surface 102 of the first connector 10 abuts against the second short bottom surface 202 of the second connector 20. Therefore, the first connecting column 103 at the edge of the first long bottom surface 101 can be buckled with the second connecting column at the edge of the second long bottom surface 201, and the first connecting column 103 at the edge of the first short bottom surface 102 can be buckled with the second connecting column at the edge of the second short bottom surface 202. The first connecting post 103 and the second connecting post are fixed by a fixing post (not labeled), so as to fixedly connect the first connecting piece 10 and the second connecting piece 20. After the first connecting elements 10 and the second connecting elements 20 are fastened, the drug delivery structure 200 can be formed.

The first connecting post 103 includes a first circular connecting post 1031 and a first semi-circular connecting post 1032. The first circular connecting column 1031 is disposed at the edges of the two long sides of the first short bottom surface 102, and the first semicircular connecting column 1032 is disposed at the middle position of the two long sides of the first short bottom surface 102.

The second connecting column includes a second circular connecting column 2031 and a second semicircular connecting column 2032, the second circular connecting column 2031 is corresponding to the positions of the first circular connecting column 1031 and the first semicircular connecting column 1032 at the setting position of the second semicircular connecting column 2032, namely, the first connecting column 103 can be just buckled with the second connecting column.

First circular connecting column 1031, first semicircular connecting column 1032, second circular connecting column 2031 and second semicircular connecting column 2032 are hollow, so that a fixing column (not marked) can penetrate through first circular connecting column 1031, first semicircular connecting column 1032, second circular connecting column 2031 and second semicircular connecting column 2032, and fixing of first connecting piece 10 and second connecting piece 20 is realized.

The length of the drug delivery structure 200 can be set according to the actual needs of the user, and therefore, the number of the first connecting member 10 and the second connecting member 20 can be freely set according to the actual needs of the user.

In this embodiment, the radial cross-section of the drug delivery structure 200 is substantially elliptical, so that the first connecting element 10 and the second connecting element 20 are stretched by the pulling force at the two top ends of the ellipse.

An edge of the first long bottom surface 101 away from the first short bottom surface 102 is provided with a U-shaped notch. The edge of the second long bottom surface 201 far from the second short bottom surface 202 is provided with a U-shaped notch completely consistent with the U-shaped notch of the first long bottom surface 101.

When the drug delivery structure 200 is required to deliver a small volume of drug (e.g., an ampoule), a gasket may be disposed along all the U-shaped cuts, so as to reduce the receiving space formed by the first connecting member 10 and the second connecting member 20. When larger volumes of medication (e.g., vials of penicillin) are to be delivered, the gaskets are eliminated. By adopting the arrangement, the medicine conveying structure 200 is suitable for medicines with various volumes, and when medicines with smaller volumes are conveyed, the phenomenon that a plurality of medicines are misplaced due to overlarge accommodating space is avoided.

Please refer to fig. 4. In this embodiment, the drug delivery structure 200 further includes a third connecting member 30, the first connecting column 103 and the second connecting column are respectively disposed on two long sides of the third connecting member 30, the first connecting column 103 of the third connecting member 30 is fastened to the second connecting column of the second connecting member 20 and then fixedly connected to the fixing column (not labeled), and the second connecting column of the third connecting member 30 is fastened to the first connecting column 103 of the first connecting member 10 and then fixedly connected to the fixing column (not labeled).

The third connecting member 30 is sheet-shaped, and the third connecting member 30 includes a third long bottom surface 301, and a first connecting post 103 and a second connecting post disposed on opposite long sides of the third long bottom surface 301. The third connecting member 30 is provided to widen the accommodating space formed by the first connecting member 10 and the second connecting member 20, so as to manage and control larger-sized medicines.

In this embodiment, the first connecting columns 103 comprise discontinuously arranged first circular connecting columns 1031 and first semicircular connecting columns 1032, and the first circular connecting columns 1031 and the first semicircular connecting columns 1032 are on one axis; the second connecting column comprises a second circular connecting column 2031 and a second semicircular connecting column 2032 which are arranged discontinuously, and the second circular connecting column 2031 and the second semicircular connecting column 2032 are arranged on the same axis.

In other embodiments, the first connecting post 103 may include only one first circular connecting post 1031, and the second connecting post may include only one second circular connecting post 2031. That is, the first connecting post 103 and the second connecting post can be fixed by fixing posts (not labeled).

Based on all the above embodiments, the radial diameters of the first circular connecting column 1031, the first semicircular connecting column 1032, the second circular connecting column 2031 and the second semicircular connecting column 2032 are equal. The first, second and third short bottom surfaces 102, 202 and 301 have the same width.

Please refer to fig. 1. In this embodiment, the drug delivery structure 200 further comprises a light barrier 204, and the light barrier 204 is vertically disposed on the short bottom surface of the first connecting member 10 or the short bottom surface of the second connecting member 20.

Please refer to fig. 2. In the present embodiment, the light blocking sheet 204 is disposed on the second short bottom surface 202 of the second connecting member 20 and perpendicular to the second short bottom surface 202 of the second connecting member 20. The light blocking plate 204 is used for blocking the light transmitted by the laser counter, and the light blocking plate counts once every time the light is blocked.

The medicine conveying structure 200 is fastened by the first connecting piece 10 and the second connecting piece 20 in pairs and then fixed by the fixing columns (not marked), so that the two short bottom surfaces of the first connecting piece 10 and the second connecting piece 20 are connected and then form an accommodating space with the two long bottom surfaces of the first connecting piece 10 and the second connecting piece 20 for accommodating medicines, and only one medicine can be placed in the accommodating space formed by the two adjacent first connecting pieces 10 and the second connecting pieces 20. In the process of rotating the medicine conveying structure 200, the medicine in the accommodating space can be driven to move, and then the medicine conveying is realized.

If the volume of the medicine is larger, the third connecting piece 30 is added to expand the accommodating space, that is, the first connecting piece 10, the second connecting piece 20 and the third connecting piece 30 together form the accommodating space for placing the medicine. Wherein, the thickness of the first connecting piece 10, the second connecting piece 20 and the third connecting piece 30 and the width of each bottom surface can be adjusted according to the size of the medicine to be delivered.

If the volume of the medicine is small, only the first connecting member 10 and the second connecting member 20 are used to form a receiving space for placing the medicine. If the formed accommodating space can accommodate two drugs at the same time, gaskets need to be disposed at the openings of the first connecting member 10 and the second connecting member 20, so as to reduce the accommodating space and prevent a user from accommodating two drugs in one accommodating space at the same time.

Fig. 5 is a block diagram of a drug delivery device.

A drug delivery device comprising the above drug delivery structure 200, a source drive module 502 for providing a driving force, a main drive module 503 and a housing 501;

the driving force of the source driving module 502 is conducted to the main driving module 503; the primary drive module 503 is configured to drive the drug delivery structure 200 to rotate around the primary drive module 503; when the drug delivery structure 200 rotates, the drug in the drug delivery structure 200 is driven to move; the housing 501 is used for housing the source drive module 502, the primary drive module 503 and the drug delivery structure 200; the housing 501 is also provided with a drug outlet.

In this embodiment, the source driving module 502 includes a motor 5021 and a first rotating wheel 5022, the motor 5021 is fixedly connected to the first rotating wheel 5022, and the motor 5021 rotates to drive the first rotating wheel 5022 to rotate.

A rotating shaft of the motor 5021 is fixedly connected with an axis of the first rotating wheel 5022, and the motor 5021 drives the first rotating wheel 5022 to rotate in the rotating process. Therefore, the first rotating wheel 5022 drives the other rotating wheels connected with the first rotating wheel to rotate through gear transmission.

The main driving module 503 comprises a third rotating wheel 5032, a first rotating shaft 5033 and a first chain wheel 5031;

please refer to fig. 6. The first rotating shaft 5033 penetrates through the first sprocket 5031, one free end of the first rotating shaft 5033 is fixedly connected with the axis of the third rotating wheel 5032, and the other free end is accommodated in the outer shell 501; when the third rotating wheel 5032 rotates, the first rotating shaft 5033 is driven to rotate, so as to drive the first chain wheel 5031 to rotate.

In the case of not using the transmission module 505, the first wheel 5022 is directly engaged with the third wheel 5032, and when the first wheel 5022 rotates, the third wheel 5032 can be driven to rotate. The axle of the third wheel 5032 is fixedly connected to the first axle 5033, and the first axle 5033 is fixedly connected to the first sprocket 5031. Therefore, when the third rotating wheel 5032 rotates, the first rotating shaft 5033 and the first sprocket 5031 are driven to rotate simultaneously.

The tooth spaces and teeth of the first sprocket 5031 are configured to engage with the first connecting post 103, the first short bottom surface 102, the second connecting post, and the second short bottom surface 202 of the drug delivery structure 200. That is, the first connecting pin 103 and the second connecting pin fall into the groove of the first sprocket 5031, and the teeth of the first sprocket 5031 fall into the first short bottom surface 102 and the second short bottom surface 202. If a third connector 30 is added to the drug delivery structure 200. The teeth of the first sprocket 5031 fall into the first short bottom surface 102, the second short bottom surface 202 and the third long bottom surface 301.

In this embodiment, the first rotating shaft 5033 is trimmed in the radial direction so that the first rotating shaft 5033 and the first sprocket 5031 do not displace relative to each other.

Please refer to fig. 6. In this embodiment, the drug delivery device further comprises a transmission module 505 connecting the source drive module 502 and the active drive module, respectively;

the transmission module 505 is used for transmitting the driving force of the source driving module 502 to the main driving module 503.

The transmission module 505 comprises a second wheel 505, the second wheel 505 is connected with the source driving module 502, and when the source driving module 502 rotates, the second wheel 505 is driven to rotate.

Please refer to fig. 7. The drug delivery device further comprises a slave drive module 506, wherein the slave drive module 506 is arranged opposite to the master drive module 503 such that the delivery module rotates around the master drive module 503 and the slave drive module 506 simultaneously.

The slave drive module 506 includes a second rotating shaft 5063 and a second sprocket 5061;

the second rotating shaft 5063 is arranged in the second chain wheel 5061 in a penetrating manner, and a free end of the second rotating shaft 5063 is accommodated in the outer shell 501; when the first sprocket 5031 rotates, the first sprocket 5031 further drives the first rotating shaft 5033 to rotate.

In this embodiment, the slave drive module 506 further includes a sleeve 5062, a spring 5064, and a fastener 5065. The sleeve 5062 is respectively sleeved on two free ends of the second rotating shaft 5063, and the radially extended free end of the sleeve 5062 is connected with the fixing member 5065. The spring 5064 is disposed over the free end of the sleeve 5062. During rotation from the drive module 506, when a pulling force is generated in the radial direction, the sleeve 5062 and the spring 5064 are deformed to cancel the pulling force. As compressive forces are generated radially from the rotation of the drive module 506, the sleeve 5062 and spring 5064 deform to counteract the pulling force. Thus, the drug delivery structure 200 can be made to rotate tightly around the master drive module 503 and the slave drive module 506.

Please refer to fig. 8.

The source driving module 502, the transmission module 505 and the main driving module 503 are sequentially arranged in a hollow space formed by the drug delivery structure 200, wherein the first sprocket 5031 of the main driving module 503 is attached to the drug delivery structure 200. Since the arrangement of the tooth grooves and the teeth of the first coupling is completely matched with the first coupling post 103, the second coupling post, the first short bottom surface 102 and the second short bottom surface 202 of the medicine delivery structure 200, the medicine delivery structure 200 can be driven to rotate around the main driving module 503 when the main driving module 503 rotates.

For more stable rotation of the drug delivery structure 200, a slave drive module 506 is provided at the other end of the drug delivery structure 200. Wherein the second sprocket 5061 of the slave drive module 506 is structurally identical to the first sprocket 5031. Thus, the second sprocket 5061 is also capable of driving the drug delivery structure 200 to rotate around the main drive module 503.

Please refer to fig. 8 and fig. 9. The housing 501 comprises a containing groove and a top cover; the receiving slot is used for receiving the source driving module 502, the main driving module 503 and the drug delivery structure 200, and the receiving slot is further provided with the drug outlet; one side of the opening of the containing groove is movably connected with the top cover.

The drug delivery device further comprises a first bottom cover (not shown) and a second bottom cover (not shown), wherein the first bottom cover (not shown) and the second bottom cover (not shown) respectively cover two sides formed when the drug delivery structure 200 rotates around the main drive module 503.

Based on all the above embodiments, the source driving module 502 provides a driving force to drive the transmission module 505, so that the transmission module 505 transmits the driving force to the main driving module 503, and thus the main driving module 503 can drive the drug delivery structure 200 to rotate around the main driving module 503. Meanwhile, the slave driving module 506 is provided, so that the drug delivery structure 200 can rotate around the master driving module 503 and the slave driving module 506 more stably. After the housing 501 accommodates the drug delivery structure 200, the source drive module 502, the transmission module 505, the master drive module 503, and the slave drive module 506, the drugs are placed in the accommodating spaces of the drug delivery structure 200, and each accommodating space can only store one drug. Therefore, in the process of rotating the medicine conveying structure 200, the medicine can be driven to move together, when medicine is required to be taken, the medicine conveying structure 200 is controlled to move to a specific position, the medicine is moved to the opening of the shell 501, the medicine can automatically drop, and the function of taking the medicine by one branch is achieved.

In other embodiments, the transfer module and/or the slave drive module 506 may not be used. The function of single drug management and control can be realized.

Adopt above-mentioned medicine conveyer, can manage and control single medicine. A medicine is placed in each accommodating space of the medicine conveying structure 200, and the size of the accommodating space can be adjusted according to the size of the medicine, so that the medicine conveying structure can just accommodate a single medicine. Compare traditional single medicine management and control structure, above-mentioned medicine conveyer's structure is more simple and convenient, and can adjust accommodating space according to the volume of management and control medicine, need not to change the major structure, increases or reduces the medicine that the packing ring just can realize compatible multiple specification on original basis.

The drug delivery device provides driving force through the source driving module 502, so that the main driving module 503 rotates, and then the main driving module 503 drives the drug delivery structure 200 to move, and the drug placed in the drug delivery structure 200 can move along with the drug delivery structure 200, and the source driving module 502, the main driving module 503 and the drug delivery structure 200 are contained in the shell 501, so that the drug can be prevented from scattering in the delivery process, and the drug delivery is realized. Compared with the traditional medicine conveying device, the medicine conveying device has the advantages that components are reduced, and further the product cost is reduced.

The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.

The above-mentioned embodiments only represent some embodiments of the present invention, and the description thereof is specific and detailed, but not to be construed as limiting the scope of the present invention. It should be noted that, for those skilled in the art, without departing from the spirit of the present invention, several variations and modifications can be made, which are within the scope of the present invention. Therefore, the protection scope of the present invention should be subject to the appended claims.

Claims

1. A medicine conveying structure is characterized by comprising a fixed column, a plurality of first connecting pieces and a plurality of second connecting pieces;

the second connecting piece is generally L-shaped, and two long side edges of the short bottom surface of the second connecting piece are respectively provided with a second connecting column corresponding to the first connecting column;

after the first connecting columns and the second connecting columns are buckled pairwise, the medicine conveying structure is formed by fixedly connecting the fixing columns.

2. The drug delivery structure according to claim 1, further comprising a third connecting member, wherein the first connecting post and the second connecting post are respectively disposed on two long sides of the third connecting member, the first connecting post of the third connecting member is fastened with the second connecting post of the second connecting member and then fixedly connected with the fixing post, and the second connecting post of the third connecting member is fastened with the first connecting post of the first connecting member and then fixedly connected with the fixing post.

3. The drug delivery structure of claim 1, wherein the first connecting column comprises intermittently disposed first circular connecting columns and first semi-circular connecting columns, the first circular connecting columns and the first semi-circular connecting columns being on one axis; the second connecting column comprises a second circular connecting column and a second semicircular connecting column which are discontinuously arranged, and the second circular connecting column and the second semicircular connecting column are arranged on the same axis.

4. The medication delivery structure of claim 1, further comprising a light barrier disposed perpendicularly to the minor bottom surface of the first connector or the minor bottom surface of the second connector.

5. A medicament delivery device comprising a medicament delivery structure according to any of claims 1 to 4, a source drive module for providing a driving force, a primary drive module and a housing;

6. The device of claim 5, wherein the source drive module comprises a motor and a first wheel, the motor being fixedly coupled to the first wheel, the motor rotating to rotate the first wheel.

7. The device according to claim 5, further comprising a transmission module connecting the source drive module and the primary drive module, respectively;

8. The device of claim 7, wherein the transmission module comprises a second wheel, the second wheel being coupled to the source drive module, the source drive module driving the second wheel to rotate when the source drive module rotates.

9. The device of claim 5, wherein the main drive module comprises a third wheel, a first shaft, and a first sprocket;

10. The device of claim 5, further comprising a slave drive module and a transfer module, the slave drive module being disposed opposite the master drive module such that the transfer module simultaneously rotates about the master drive module and the slave drive module.

11. The device of claim 10, wherein the slave drive module comprises a second shaft, a fourth wheel, and a second sprocket;

the second rotating shaft penetrates through the second chain wheel, one free end of the second rotating shaft is movably connected with the axis of the fourth rotating wheel, and the other free end of the second rotating shaft is accommodated in the shell; when the fourth rotating wheel rotates, the second chain wheel is driven to rotate, and then the second rotating shaft is driven to rotate.

12. The device according to claim 5, wherein the housing comprises a receiving slot, a cap; the accommodating groove is used for accommodating the source driving module, the main driving module and the medicine conveying structure, and is also provided with the medicine outlet; one side of the opening of the containing groove is movably connected with the top cover.

13. The device of claim 5, further comprising a first bottom cap and a second bottom cap, wherein the first bottom cap and the second bottom cap respectively cover two sides of the drug delivery structure when the drug delivery structure rotates around the main drive module.